Does Ertapenem Cause Fatigue?
Fatigue is not a commonly reported side effect of ertapenem based on FDA labeling and clinical trial data, though it has been documented in a small percentage of patients.
Evidence from FDA Drug Label and Clinical Trials
According to the FDA-approved drug label for ertapenem, fatigue (listed as "asthenia/fatigue") was reported as an adverse event in clinical trials, but it occurred in less than 2% of patients and was not among the most common drug-related adverse experiences 1. The most frequent adverse effects were:
- Diarrhea (5.5%)
- Infused vein complications (3.7%)
- Nausea (3.1%)
- Headache (2.2%)
- Vaginitis in females (2.1%)
Fatigue was classified as an uncommon adverse event occurring at a rate of >0.1% but <2% 1.
Clinical Trial Safety Data
A comprehensive safety review of ertapenem involving 2,046 patients across multiple Phase II and III clinical trials confirmed that fatigue was not among the most common drug-related adverse events 2. The drug was generally well tolerated with most adverse events being mild to moderate in severity 2, 3.
Important Clinical Context
While fatigue itself is uncommon with ertapenem, there are several important considerations:
Neurotoxicity Risk
Ertapenem can cause central nervous system effects in high-risk patients, particularly those with:
- Advanced age (>65 years)
- Chronic kidney disease or reduced creatinine clearance
- Pre-existing neurological conditions
- Hypoalbuminemia
These neurological effects may manifest as altered mental status, confusion, somnolence, or stupor—which could be perceived as fatigue 1, 4, 5.
When to Suspect Ertapenem-Related Symptoms
If a patient on ertapenem reports new-onset fatigue, particularly if accompanied by:
- Altered mental status or confusion
- Dizziness or somnolence
- Myoclonic movements
- Any neurological changes
Consider ertapenem-induced neurotoxicity rather than simple fatigue, especially in elderly patients or those with renal impairment 4, 5. These symptoms typically resolve completely upon discontinuation of the drug.
Bottom Line
Ertapenem does not commonly cause fatigue as an isolated symptom. If fatigue occurs in a patient receiving ertapenem, consider:
- Alternative causes: The underlying infection, concurrent medications, or the patient's overall clinical condition
- Neurotoxicity: If the patient is elderly or has renal impairment and exhibits any neurological symptoms beyond simple tiredness
- Drug discontinuation: If ertapenem-related neurotoxicity is suspected, as symptoms are reversible 4, 5
The drug's overall safety profile is comparable to other broad-spectrum antibiotics like piperacillin-tazobactam and ceftriaxone 2, 3.